Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Astrea Bioseparations acquires Delta Precision, a leading manufacturer of chromatography columns for biomanufacturing
Astrea Bioseparations, a leading provider of high-quality bioseparation and purification technologies, has announced the acquisition […]
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences today announced they have entered into a strategic collaboration and licensing […]
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
AbbVie and Immunome, a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]
Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®
Acorda Therapeutics has announced that on December 31, 2022 it entered into a new long-term […]
New Partnership to Boost Research into Vaccines for Cancer
Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]
Orbit Discovery and SanegeneBio Collaborate to Identify Targeting Peptides for RNAi Drugs
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, has announced it has […]
Turbine’s AI-powered Cancer Cell Simulations Will Be Used to Identify Novel Disease Positioning Strategies in Cancer Research UK’s Latest Biotech Partnership
Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder […]
IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
IntoCell has announced the signing of a Material Transfer Agreement (MTA) with option to license […]
Amneal Announces Strategic European Partnership with Orion Corporation
Amneal Pharmaceuticals, has announced it has signed a long-term license agreement with Orion Corporation to […]
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more